Literature DB >> 28655744

Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures.

Rob W van der Pluijm1, James Watson1, Charles J Woodrow2.   

Abstract

Entities:  

Keywords:  artemether; failure; falciparum; lumefantrine; malaria; recrudescence; resistance

Mesh：

Substances：

Year:  2017        PMID： 28655744      PMCID： PMC5487650          DOI： 10.1128/AAC.00721-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  15 in total

1.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Authors:  M B Reed; K J Saliba; S R Caruana; K Kirk; A F Cowman
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Rescuing artemisinin combination therapy in Africa.

Authors:  Colin J Sutherland
Journal:  Lancet Glob Health       Date:  2016-11-11       Impact factor: 26.763

3.  High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.

Authors:  Klara Sondén; Katja Wyss; Irina Jovel; Antero Vieira da Silva; Anton Pohanka; Muhammad Asghar; Manijeh Vafa Homann; Lars L Gustafsson; Urban Hellgren; Anna Färnert
Journal:  Clin Infect Dis       Date:  2016-10-24       Impact factor: 9.079

4.  Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.

Authors:  Hypolite Muhindo Mavoko; Carolyn Nabasumba; Raquel Inocêncio da Luz; Halidou Tinto; Umberto D'Alessandro; Andrew Kambugu; Vito Baraka; Anna Rosanas-Urgell; Pascal Lutumba; Jean-Pierre Van Geertruyden
Journal:  Lancet Glob Health       Date:  2016-11-11       Impact factor: 26.763

5.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

Review 6.  The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.

Authors: 
Journal:  Lancet Infect Dis       Date:  2015-03-16       Impact factor: 25.071

7.  A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial.

Authors: 
Journal:  PLoS Med       Date:  2011-11-08       Impact factor: 11.069

8.  pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

Authors:  Colin J Sutherland; Paul Lansdell; Mandy Sanders; Julian Muwanguzi; Donelly A van Schalkwyk; Harparkash Kaur; Debbie Nolder; Julie Tucker; Hayley M Bennett; Thomas D Otto; Matthew Berriman; Trupti A Patel; Roderick Lynn; Effrossyni Gkrania-Klotsas; Peter L Chiodini
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies.

Authors:  Maciej F Boni; Nicholas J White; J Kevin Baird
Journal:  PLoS Med       Date:  2016-03-29       Impact factor: 11.069

10.  Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.

Authors:  Mateusz M Plucinski; Pedro Rafael Dimbu; Aleixo Panzo Macaia; Carolina Miguel Ferreira; Claudete Samutondo; Joltim Quivinja; Marília Afonso; Richard Kiniffo; Eliane Mbounga; Julia S Kelley; Dhruviben S Patel; Yun He; Eldin Talundzic; Denise O Garrett; Eric S Halsey; Venkatachalam Udhayakumar; Pascal Ringwald; Filomeno Fortes
Journal:  Malar J       Date:  2017-02-02       Impact factor: 2.979
View more
  1 in total

1.  Reply to van der Pluijm et al., "Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures".

Authors:  Colin J Sutherland
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.